Average Co-Inventor Count = 5.58
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The University of Texas System (9 from 5,450 patents)
2. Millennium Pharmaceuticals Limited (9 from 850 patents)
3. Johns Hopkins University (1 from 3,687 patents)
4. Mayo Foundation for Medical Education and Research (1 from 1,746 patents)
5. Vermillion Corporation (1 from 26 patents)
6. Vermilllion, Inc. (1 from 3 patents)
7. Ut Board of Regents (1 from 2 patents)
12 patents:
1. 10533227 - Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
2. 8323906 - Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
3. 8221984 - Biomarkers for ovarian cancer
4. 8080368 - Compositions and methods for the identification, assessment, prevention and therapy of human cancers
5. 7871775 - Compositions and methods for the identification, assessment, prevention and therapy of human cancers
6. 7705120 - Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
7. 7601505 - Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
8. 7510842 - Biomarker for ovarian and endometrial cancer: hepcidin
9. 7504222 - Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
10. 7494775 - Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
11. 7470509 - Compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
12. 7183401 - NOEY2 gene compositions and methods of use